论文信息 - Bivalirudin Superiority in Pediatric Berlin Hearts: Too Early to Draw Conclusions? - 字舞流文

Bivalirudin Superiority in Pediatric Berlin Hearts: Too Early to Draw Conclusions?

T. Seelhammer | P. Wieruszewski | Krzysztof Laudanski

[1] D. Salerno,et al. Bivalirudin Compared to Heparin as the Primary Anticoagulant in Pediatric Berlin Heart Recipients , 2023, ASAIO journal.

[2] M. Hamzah,et al. Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared With Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation , 2023, Critical Care Medicine.

[3] K. Mara,et al. Heparin Versus Bivalirudin for Anticoagulation in Adult Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis , 2022, ASAIO journal.

[4] Gomathi Krishnan,et al. Discordant aPTT and Anti-Xa Values and Outcomes in Hospitalized Patients Treated with Intravenous Unfractionated Heparin , 2013, The Annals of pharmacotherapy.

[5] Amy F Rosenberg,et al. The Use of Anti-Xa Assay to Monitor Intravenous Unfractionated Heparin Therapy , 2010, Journal of pharmacy practice.